ANIXA BIOSCIENCES, INC. Cash and Cash Equivalents
ANIXA BIOSCIENCES, INC. (ANIX) had Cash and Cash Equivalents of $1.40 million as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-09-09
- 2026-07-31: Cash and Cash Equivalents, at Carrying Value $1.40M.
- 2026-04-30: Cash and Cash Equivalents, at Carrying Value $1.48M.
- 2026-01-31: Cash and Cash Equivalents, at Carrying Value $1.55M.
- 2025-10-31: Cash and Cash Equivalents, at Carrying Value $1.24M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-07-31 | $1.40M 10-Q · filed 2026-09-09 | |
| 2026-04-30 | $1.48M 10-Q · filed 2026-06-10 | |
| 2026-01-31 | $1.55M 10-Q · filed 2026-03-09 | |
| 2025-10-31 | $1.24M 10-Q · filed 2026-09-09 | |
| 2025-07-31 | $1.50M 10-Q · filed 2025-09-10 | |
| 2025-04-30 | $1.91M 10-Q · filed 2025-05-28 | |
| 2025-01-31 | $1.05M 10-Q · filed 2025-03-11 | |
| 2024-10-31 | $1.27M 10-K · filed 2026-01-12 | |
| 2024-07-31 | $1.23M 10-Q · filed 2024-09-06 | |
| 2024-04-30 | $995.00K 10-Q · filed 2024-06-04 | |
| 2024-01-31 | $998.00K 10-Q · filed 2024-03-12 | |
| 2023-10-31 | $915.00K 10-K · filed 2025-01-10 | |
| 2023-07-31 | $3.20M 10-Q · filed 2023-09-06 | |
| 2023-04-30 | $5.62M 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $9.79M 10-Q · filed 2023-03-17 | |
| 2022-10-31 | $12.36M 10-K · filed 2024-01-16 | |
| 2022-07-31 | $24.25M 10-Q · filed 2022-09-09 | |
| 2022-04-30 | $27.73M 10-Q · filed 2022-06-10 | |
| 2022-01-31 | $29.78M 10-Q · filed 2022-03-11 | |
| 2021-10-31 | $29.13M 10-K · filed 2023-01-04 | $29.13M 10-K · filed 2022-01-04 |
| 2021-07-31 | $27.22M 10-Q · filed 2021-09-01 | |
| 2021-04-30 | $27.70M 10-Q · filed 2021-06-10 | |
| 2021-01-31 | $11.98M 10-Q · filed 2021-03-11 | |
| 2020-10-31 | $6.42M 10-K · filed 2022-01-04 | |
| 2020-07-31 | $5.93M 10-Q · filed 2020-09-08 | |
| 2020-04-30 | $2.89M 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $2.82M 10-Q · filed 2020-03-09 | |
| 2019-10-31 | $3.49M 10-K · filed 2021-01-07 | |
| 2019-07-31 | $4.40M 10-Q · filed 2019-09-06 | |
| 2019-04-30 | $3.82M 10-Q · filed 2020-06-09 | |
| 2019-01-31 | $4.15M 10-Q · filed 2020-03-09 | |
| 2018-10-31 | $3.06M 10-Q · filed 2020-06-09 | |
| 2018-07-31 | $2.59M 10-Q · filed 2019-09-06 | |
| 2018-04-30 | $4.17M 10-Q · filed 2019-06-12 | |
| 2018-01-31 | $2.85M 10-Q · filed 2019-03-13 | |
| 2017-10-31 | $3.34M 10-K · filed 2020-01-09 | |
| 2017-07-31 | $1.83M 10-Q · filed 2018-09-07 | |
| 2017-04-30 | $2.88M 10-Q · filed 2018-06-11 | |
| 2017-01-31 | $1.40M 10-Q · filed 2018-03-09 | |
| 2016-10-31 | $2.49M 10-K · filed 2019-01-11 | |
| 2016-07-31 | $2.05M 10-Q · filed 2017-09-08 | |
| 2016-04-30 | $2.61M 10-Q · filed 2017-05-26 | |
| 2016-01-31 | $3.98M 10-Q · filed 2017-03-16 | |
| 2015-10-31 | $4.37M 10-K · filed 2018-01-09 | |
| 2015-07-31 | $5.16M 10-Q · filed 2016-08-19 | |
| 2015-04-30 | $6.08M 10-Q · filed 2016-05-20 | |
| 2015-01-31 | $7.81M 10-Q · filed 2016-02-19 | |
| 2014-10-31 | $3.36M 10-K · filed 2016-12-08 | |
| 2014-07-31 | $3.65M 10-Q · filed 2015-08-18 | |
| 2014-04-30 | $617.72K 10-Q · filed 2015-05-22 | |
| 2014-01-31 | $776.14K 10-Q · filed 2015-03-09 | |
| 2013-10-31 | $898.17K 10-K · filed 2015-12-23 | |
| 2013-07-31 | $982.03K 10-Q · filed 2014-09-15 | |
| 2013-04-30 | $1.27M 10-Q · filed 2014-06-16 | |
| 2013-01-31 | $1.71M 10-Q · filed 2014-03-17 | |
| 2012-10-31 | $339.69K 10-K · filed 2015-01-29 | |
| 2012-07-31 | $101.53K 10-Q/A · filed 2013-09-20 | |
| 2012-04-30 | $130.73K 10-Q/A · filed 2013-06-19 | |
| 2012-01-31 | $463.04K 10-Q/A · filed 2013-03-25 | |
| 2011-10-31 | $774.04K 10-K/A · filed 2014-01-17 | |
| 2011-07-31 | $551.40K 10-Q · filed 2012-09-14 | |
| 2011-04-30 | $347.10K 10-Q · filed 2012-06-14 | |
| 2011-01-31 | $978.96K 10-Q · filed 2012-03-16 | |
| 2010-10-31 | $1.09M 10-K · filed 2013-01-29 | |
| 2010-07-31 | $1.41M 10-Q/A · filed 2011-10-14 | |
| 2009-10-31 | $1.45M 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |